Справка
x
Поиск
Закладки
Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Рак пищевода и кардии
Список литературы
Поставить закладку
Anonymous International Agency for Research on Cancer. Tobacco smoking, in evaluation of carcinogenic risks to humans. International Agency for Research on Cancer, 1996:38.
Anonymous International Agency for Research on Cancer. Alcohol drinking, in evaluation of carcinogenic risks to humans. International Agency for Research on Cancer, 1998:44.
Trivers K.F., Sabatino S.A., Stewart S.L. Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int J Cancer 2008;123:1422-1428.
Devesa S.S., Blot W.J., Fraumeni J.F.Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer, 1998;83:2049-2053.
Steevens J., Botterweck A.A.M., Dirx M.J.M. et al. Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol, 2010;22:669-678.
Lagergren J., Bergstrom R., Lindgren A., Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. The New England Journal of Medicine, 1999; 340(11): 825–831.
Давыдов М.И., Тер-Ованесов М.Д., Стилиди И.С. и др. Пищевод Баррета: от теоретических основ к практическим рекомендациям. Практическая онкология. - 2003.- Т. 4. - № 2. - С. 109–119.
Ferlay J., Shin H.R., Bray F. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 // Int. J. Cancer. - Vol. 127-2010. - p. 2893–2917.
Состояние онкологической помощи населению России в 2022 году // под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. - М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2023. - 239 с. ISBN 978-5-85502-283-4.
Amin M.B. et al. (eds.). AJCC Cancer Staging Manual, Eighth Edition, American Joint Committee on Cancer 2017. Pp. 185-203.
О.Р. Мельников.
Рак пищевода: клиническая картина и стадирование заболевания. - Практическая онкология. - 2003. - Т. 4. - № 2. - С. 66-69.
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Esophageal and Esophagogastric Junction Cancers Version 1.2019 - March 14, 2019. https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf.
van Nistelrooij A.M.J., Dinjens W.N.M., Wagner A. et al. Hereditary Factors in Esophageal Adenocarcinoma. Gastrointest Tumors. 2014 Jun; 1(2): 93–98.
Graham D.Y., Schwartz J.T., Cain G.D., et al. Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma. Gastroenterology 1982;82:228-31.
Bloomfeld R.S., Bridgers D.I. 3rd, Pineau B.C. Sensitivity of upper endoscopy in diagnosing esophageal cancer. Dysphagia. 2005 Fall;20(4):278-82.
Miyata H., Yamasaki M., Takiguchi S., et al. Prognostic value of endoscopic biopsy findings after induction chemoradiotherapy with and without surgery for esophageal cancer. Ann Surg 2011;253:279-84.
Owaki T., Matsumoto M., Okumura H., et al. Endoscopic ultrasonography is useful for monitoring the tumor response of neoadjuvant chemoradiation therapy in esophageal squamous cell carcinoma. Am J Surg 2012;203:191-7.
Eloubeidi M.A., Cerfolio R.J., Bryant A.S., et al. Efficacy of endoscopic ultrasound in patients with esophageal cancer predicted to have N0 disease. Eur J Cardiothorac Surg 2011;40:636-41.
Chao Y.K., Yeh C.J., Lee M.H., et al. Factors associated with false-negative endoscopic biopsy results after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma. Medicine (Baltimore) 2015;94:e588.
Yen T.J., Chung C.S., Wu Y.W., et al. Comparative study between endoscopic ultrasonography and positron emission tomography computed tomography in staging patients with esophageal squamous cell carcinoma. Dis Esophagus 2012;25:40-7.
Molena D., Sun H.H., Badr A.S., et al. Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy. Dis Esophagus 2014;27:355-9.
Pongpornsup S., Posri S., Totanarungroj K. Diagnostic accuracy of multidetector computed tomography (MDCT) in evaluation for mediastinal invasion of esophageal cancer. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2012;95(5):704–11. Epub 2012/09/22. pmid:22994032.
Choi J., Kim S.G., Kim J.S., Jung H.C., Song I.S. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surgical endoscopy. 2010;24(6):1380–6. Epub 2009/12/25. doi: 10.1007/s00464-009-0783-x pmid:20033712.
Lowe V.J., Booya F., Fletcher J.G., et al. Comparison of positron emission tomography, computed tomography and endoscopic ultrasound in the initial staging of patients with oesophageal cancer // Molecular Imaging Biol. – 2005. – Vol. 7 (6). – p. 422-430.
Kim T.J., Kim H.Y., Lee K.W., Kim M.S. Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics. 2009;29:403–421.
Swisher S.G., Maish M., Erasmus J.J., et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 2004;78:1152-60; discussion 1152-60.
Kitagawa Y., Uno T., Oyama T., et al. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. Esophagus. 2019 Jan;16(1):1-24. doi: 10.1007/s10388-018-0641-9.
College of American pathologists. Protocol for the Examination of Specimens From Patients With Carcinoma of the Esophagus. Version: Esophagus 4.0.0.0 Protocol Posting Date: June 2017.
https://documents.cap.org/protocols/cp-esophagus-17protocol-4000.pdf
.
Rice T.W., Apperson-Hansen C., DiPaola LM et al. Worldwide Esophageal Cancer Collaboration: clinical staging data. Dis Esophagus.2016;7:707-14.
Gemmill E.H., McCulloch P. Systematic review of minimally invasive resection for gastro-oesophageal cancer // Br. J. Surg. – 2007. – Vol. 94(12). – p. 1461-1467.
Kim T.J., Kim H.Y., Lee K.W., et al. Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics 2009;29:403-21.
van Vliet E.P., Heijenbrok-Kal M.H., Hunink M.G., et al. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 2008;98: 547-57.
Sjoquist K.M., Burmeister B.H., Smithers B.M., et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011 Jul;12(7):681-92.
Al-Batran S.E., Homann N., Pauligk C., et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1.
P. van Hagen., M.C.C.M. Hulshof., J.J.B. van Lanschot et al. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer. N Engl J Med 2012;366:2074-84.
F. Lordick., C. Mariette., K. Haustermans., et al. Oesophageal Cancer: ESMO Clinical Practice Guidelines. Ann Oncol (2016) 27 (suppl 5): v50-v57.
Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999 May 5; 281(17):1623-7.
Izbicki J.R., Broering D.C., Yekebas E.F., et al. Surgery of the Esophagus. Textbook and Atlas of Surgical Practice // Steinkopff Verlag. – 2009. – 386 p.
Vellayappan B.A., Soon Y.Y., Ku G.Y., et al. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer. Cochrane Database of Systematic Reviews 2017, Issue 8. Art. No.: CD010511. DOI: 10.1002/14651858.CD010511.pub2.
Orringer M.B., Marshall B., Chang A.C., et al. Two thousand transhiatal esophagectomies: changing trends, lessons learned // Ann Surg. – 2007. – Vol. 246(3). – p. 363-372.
Janmaat V.T., Steyerberg E.W., van der Gaast A., et al. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. Cochrane Database of Systematic Reviews 2017, Issue 11. Art. No.: CD004063. DOI: 10.1002/14651858.CD004063.pub4.
Kojima T., Muro K., Francois E., et al. Pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer: Phase III KEYNOTE-181 study. J Clin Incol. 2019;37 (suppl 4; abstr 2).
Herskovic A, Martz K, M al-Sarraf, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992,11;326(24):1593-8.
Mukherjee S, Hurt C.N., Gwynneet S. al. NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma. Eur J Cancer 2017 Mar;74:38-46.
Shankaran V., Mulcahy M.F., Hochster H.S., et al. Docetaxel, oxaliplatin, and 5-FU for the treatment of metastatic or unresectable gastric or GEJ adenocarcinomas: Preliminary results of a phase II study. Gastrointestinal Cancer Symposium 2009: Abstract 47
Shah M.A., Janjigian Y.Y., Stoller R., et al. Randomized multicenter phase II study of modified DCF versus DCF plus GF support in patient with metastatic gastric adenocarcinoma. J Clin Oncol 2015; 33:3874-79.
Kang Y.K., et al. Capecitabin/cisplatin versus 5-FU/cisplatin as first-line therapy in patient with advanced GC: a randomized pIII noninferiority trial. Ann Oncol 209; 20:666-673.
Prithviraj G K, Baksh K, Fulpet W, et al. Carboplatin and paclitaxel as first-line treatment of unresectable or metastatic esophageal or gastric cancer. Dis Esophagus 2015;28(8):782-7.
Kim G.M, et al. A randomized P-II trial of S-1/oxaliplatin versus capecitabin/oxaliplatin in advanced GC. Eur J Cancer 2012; 48:518-526.
Ford H.E., et al. Docetaxel versus active symptom control therapy for refractory oesophagogastric adenocarcinoma (COUGAR-02)^ an open-label P-III randomized controlled trial. Lancet Oncol 2014;78-86.
Kim J.Y., et al. A multi-center P-II study of docetaxel plus cisplatin as 1-line therapy in patient with metastatic squamous cell cancer. Cancer Chem Pharmacol 2010;66:31-36.
Rabenstein T. Palliative Endoscopic Therapy of Esophageal Cancer. Viszeralmedizin. 2015 Oct; 31(5): 354–359.
Okawa T., Dokiya T., Nishio M., et al. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group // Int. J. Radiat. Oncol. Biol. Phys. – 1999. – Vol. 45(3). – p.623-628.
Liu-Hua Wang et all. Application of enhanced recovery after gastric cancer surgery: An updated meta-analysis. World J Gastroenterol 2018 April 14; 24(14): 1562-1578.
Программа ускоренного выздоровления хирургических больных Fast track // под ред. И.И. Затевахина, К.В. Лядова, И.Н. Пасечника. – М.: ГЕОТАР-Медиа, 2017.
Silver J.A., Baima J. Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. Am J Phys Med Rehabil 2103; 92: 715-727.
Luther A., Gabriel J., Watson R.P., Francis N.K. The Impact of Total Body Prehabilitation on Post-Operative Outcomes After Major Abdominal Surgery: A Systematic Review. World J Surg. 2018 Sep;42(9):2781-2791.
Pisarska M., Maøczak P., Major P., Wysocki M., Budzyński A., Pędziwiatr M. Enhanced recovery after surgery protocol in oesophageal cancer surgery: Systematic review and meta-analysis. PLoSONE. 2017; 12(3): e0174382.
Low D.E., Allum W., De Manzoni G., et al. Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS
®
) Society Recommendations World J Surg (2019) 43: 299. https://doi.org/10.1007/s00268-018-4786-4.
Weijs, Teus & Berkelmans, Gijs & Nieuwenhuijzen, Grard & Ruurda, Jelle & van Hillegersberg, Richard & Soeters, Peter & Luyer, Misha. (2014). Routes for early enteral nutrition after esophagectomy. A systematic review. Clinical Nutrition. 34. 10.1016/j.clnu.2014.07.011.
Feeding Jejunostomy after esophagectomy cannot be routinely recommended. Analysis of nutritional benefits and catheter-related complications Álvarez-Sarrado, Eduardo et al. The American Journal of Surgery, Volume 217, Issue 1, 114-120.
Early Oral Feeding Following McKeown Minimally Invasive Esophagectomy An Open-label, Randomized, Controlled, Noninferiority Trial Annals of Surgery: March 2018. - Volume 267. - Issue 3. - p. 435–442. doi: 10.1097/SLA.0000000000002304.
Elles Steenhagen, Jonna K. van Vulpen, Richard van Hillegersberg, Anne M. May & Peter D. Siersema (2017): Nutrition in peri-operative esophageal cancer management, Expert Review of Gastroenterology & Hepatology. DOI: 10.1080/17474124.2017.1325320.
Swarm R.A., Abernethy A.P., Anghelescu D.L., Benedetti C., Buga S., Cleeland C., et al. Adult cancer pain. J Natl Compr Canc Netw. 2013;11(8):992-1022.
Shin K.Y., Guo Y., Konzen B., Fu J., Yadav R., Bruera E. Inpatient cancer rehabilitation: the experience of a national comprehensive cancer center. Am J Phys Med Rehabil. 2011; 90 (5): 63–S68.
Bourke L., Homer K.E., Thaha M.A., Steed L., Rosario D.J., Robb K.A. Interventions to improve exercise behaviour in sedentary people living with and beyond cancer: a systematic review. Br J Cancer. 2014; 110: 831–841.
Arends J., et al. ESPEN guidelines on nutrition in cancer patients, Clinical Nutrition (2016).
Mustian K.M., Alfano C.M., Heckler C., et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol 2017;3:961-968.
Kleckner I.R., Kamen C., Gewandter J.S., et al: Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer 2018;26:1019-1028.
Oberoi S., Zamperlini-Netto G., Beyene J., Treister NS., Sung L. Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. Send to PLoS One. 2014 Sep 8;9(9):e107418.
Ross M., Fischer-Cartlidge E. Scalp Cooling: A Literature Review of Efficacy, Safety, and Tolerability for Chemotherapy-Induced Alopecia. Clin J Oncol Nurs. 2017 (1);21(2):p. 226-233.
Jankowski J.A.Z., de Caestecker J., Love S.B., et al. Esomeprazole and aspirin in Barrett"s oesophagus (AspECT): a randomised factorial trial. Lancet. 2018 Aug 4;392(10145):400-408.
Pennathur A., Gibson M.K., Jobe B.A., Luketich J.D. Oesophageal carcinoma // Lancet. – 2013. – Vol. 381. – p.400–412.
Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T. Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5(6):649-655.
Kondrup J., Allison S.P., Elia M., Vellas B., Plauth M. Educational and Clinical Practice Committee, European Society of Parenteral and Enteral Nutrition (ESPEN). ESPEN Guidelines for Nutrition Screening 2002 Clinical Nutrition (2003) 22(4): 415–421.
Ding X., Zhang J., Li B., et al. A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy // Br. J. Radiol. – 2012. – Vol. 85 – p. 1019.
Muller J.M., Erasmi H., Stelzner M., Pichlmaier U. Surgical therapy of oesophageal carcinoma // Br. J. Surg. - 1990. - Vol. 77. - P. 845–857.
Luketich J.D., Rivera M.A., Buenaventura P.O., et al. Minimally Invasive Esophagectomy. Outcomes in 222 Patients // Ann. Surg. – 2003. – Vol. 238(4). – p. 486–495.
Matsubara T., Veda M., Vchida C., Takahashi T. Modified Stomach Roll for safer Reconstruction After Subtotal Esophagectomy // J. Surg. Oncol. – 2000. – Vol. 74. – № 12. – p. 1115-1117.
Napier K.J., Scheerer M., Misra S. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities // World J. Gastrointest. Oncol. – 2014. – Vol. 6 (5). – p. 112-120.
O’Reilly S., Forastiere A.A. Is surgery necessary with multimodality treatment of oesophageal cancer. Ann Oncol 1995; 6:519.
Rice T.W., Rusch V.W., Apperson-Hansen C., et al. Worldwide esophageal cancer collaboration. Dis Esophagus 2009; 22:1.
Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer. N Engl J Med 2006; 355:11-20.
Ajani J.A., Correa A.M., Hofstetter W.L., et al. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 2012;23: 2638-42.
Jani J.A., Xiao L., Roth J., et al. A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. Annals of Oncology 2013, 24: 2844–2849.
Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of Locally Advanced Esophageal Cancer Long-term Follow-up of a Prospective Randomized Trial (RTOG 85-01). JAMA. 1999;281(17):1623-1627.
Conroy T., Galais M.P., Raoul J.L., et al. Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial. Lancet Oncol. 2014 Mar;15(3):305-14.
Deng J., Wang C., Xiang M. et al. Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma // Diagnostic Pathology. – 2014. – Vol. 9. – p. 151.
Berger A.C., Farma J., Scott W.J., et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005;23:4330-7.
Kranzfelder M., Schuster T., Geinitz H., et al. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer // Br. J. Surg. – 2011. – Vol. 98. – p. 768-783.
O’Neill L.M., Guinan E., Doyle S.L., Bennett A.E., Murphy C., Elliott J.A., O’Sullivan J., Reynolds J.V., Hussey J. The RESTORE Randomized Controlled Trial Impact of a Multidisciplinary Rehabilitative Program on Cardiorespiratory Fitness in Esophagogastric cancer Survivorship. AnnSurg 2018;268:747–755.
B.C. Cho, K. Kato, M. Takahashi, et al. Nivolumab Versus Chemotherapy in Advanced Esophageal Squamous Cell Carcinoma (ESCC): The Phase 3 ATTRACTION-3 Study. Annals of Oncology (2019) 30 (suppl_5): v851-v934. 10.1093/annonc/mdz394.
Levine MS, Halvorsen RA. Carcinoma of the esophagus. In: Gore RM, Levine MS, editors. Textbook of gastrointestinal radiology. 4th ed. Philadelphia, PA: Elsevier; 2015. p. 366–93.
Conroy T, Galais M-P, Raoul J.C., et al. Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial. Lancet Oncol 2014 Mar;15(3):305-14.
Chen Y; Ye J, Zhu Z, et al. Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial. J Clin Oncol 2019, 37(20):1695-1703.
Kelly R.J., Ajani J.A., Kuzdzal J., et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiation therapy (CRT): First results of the CheckMate 577 study. Ann Oncol, 2020, 31 (suppl_4): S1142-S1215. LBA9_PR.
Yelena Y Janjigian, Kohei Shitara, Markus Moehler, Marcelo Garrido, Pamela Salman et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27-40. doi: 10.1016/S0140-6736(21)00797-2.
Kato K., Sun J., Shah M.A., et al. Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study. Ann Oncol, 2020, 31 (suppl_4): S1142-S1215. LBA8_PR.
Трякин А. А., Бесова Н. С., Волков Н. М., Гладков О. А., Карасева В. В., Сакаева Д. Д. и соавт. Общие принципы проведения противоопухолевой лекарственной терапии. Практические рекомендации RUSSCO, часть 1. Злокачественные опухоли, 2023 (том 13), #3s2, стр. 28–41.
Блинов Д.В., Солопова А.Г., Санджиева Л.Н., Ачкасов Е.Е. , Корабельников Д.И. с соавт. Совершенствование организации медицинской реабилитации в системе здравоохранения: анализ ситуации. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2022; Том 15, № 2. С.237-249.
Iliadis, I.P.I. (2021) Quality of life in cancer survivors after participating in a multidisciplinary rehabilitation program : a pre-post study.
Arends J, Strasser F, Gonella S, et al. ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆. ESMO Open. 2021 Jun;6(3):100092. doi: 10.1016/j.esmoop.2021.100092. PMID: 34144781; PMCID: PMC8233663
Lakshmi Sandhya, Nirmala Devi Sreenivasan, Luxitaa Goenka, et al. Randomized Double-Blind Placebo-Controlled Study of Olanzapine for Chemotherapy-Related Anorexia in Patients With Locally Advanced or Metastatic Gastric, Hepatopancreaticobiliary, and Lung Cancer. J Clin Oncol. 2023 May 10;41(14):2617-2627.
Li CQ, Wang YC, Shen SQ, et al. Effects of exercise by type and duration on quality of life in patients with digestive system cancers: A systematic review and network meta-analysis. J Sport Health Sci. 2022 Dec 15:S2095-2546(22)00122-3. doi: 10.1016/j.jshs.2022.12.008.
Zhao X, Tong S, Yang Y. The Correlation Between Quality of Life and Positive Psychological Resources in Cancer Patients: A Meta-Analysis. Front Psychol. 2022 Jun 16;13:883157. doi: 10.3389/fpsyg.2022.883157.
Brick, R., Padgett, L., Jones, J. et al. The influence of telehealth-based cancer rehabilitation interventions on disability: a systematic review. J Cancer Surviv (2022). https://doi.org/10.1007/s11764-022-01181-4]
Lambert J.E., Hayes L.D., Keegan T.J., et al. The impact of prehabilitation on patient outcomes in hepatobiliary, colorectal, and upper gastrointestinal cancer surgery: A PRISMA-accordant meta-analysis. Ann Surg. 2021; 274(1): 70-77.
Waterland J.L., McCourt O., Edbrooke L., et al. Efficacy of prehabilitation including exercise on postoperative outcomes following Abdominal cancer surgery: A systematic review and meta-analysis. Front Surg. 2021; 8: 628848.
Teixeira-Oliveira, F., Silva, G., Santos, F., C. Martins, P., & Moreira-Gonçalves, D. (2022). PREHABILITATION AND POSTOPERATIVE BURDEN OF HIGH-RISK CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Revista Portuguesa De Cirurgia, (51), 99-114. doi:10.34635/rpc.936.
Cao Y, Han D, Zhou X, Han Y, Zhang Y, Li H. Effects of preoperative nutrition on postopera-tive outcomes in esophageal cancer: a systematic review and meta-analysis. Dis Esophagus. 2022 Mar 12;35(3):doab028. doi: 10.1093/dote/doab028.
Weimann A, Braga M, Carli F, et al.: ESPEN practical guideline: Clinical nutrition in surgery. Clin Nutr. 2021, 40:4745-61. 10.1016/j.clnu.2021.03.031
Zhang Y, Tan S, Wu G. ESPEN practical guideline: Clinical nutrition in surgery. Clin Nutr. 2021 Sep;40(9):5071. doi: 10.1016/j.clnu.2021.07.012.
Sadeghi F, Mockler D, Guinan EM, Hussey J, Doyle SL. The Effectiveness of Nutrition Interventions Combined with Exercise in Upper Gastrointestinal Cancers: A Systematic Review. Nutrients. 2021 Aug 18;13(8):2842. doi: 10.3390/nu13082842. PMID: 34445002; PMCID: PMC8400981
Moorthy, K., Halliday, L. Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS and Oesophagectomy. Ann Surg Oncol 29, 224–228 (2022).
https://doi.org/10.1245/s10434-021-10384-5
Sindler DL, Mátrai P, Szakó L, Berki D, Berke G, Csontos A, Papp C, Hegyi P, Papp A. Faster recovery and bowel movement after early oral feeding compared to late oral feeding after upper GI tumor resections: a meta-analysis. Front Surg. 2023 May 25;10:1092303. doi: 10.3389/fsurg.2023.1092303.
Tazreean R, Nelson G, Twomey R. Early mobilization in enhanced recovery after surgery pathways: current evidence and recent advancements. J Comp Eff Res. 2022 Feb;11(2):121-129. doi: 10.2217/cer-2021-0258.
National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain, version 1.2022 — January 19, 2022. Available at https://www.nccn.org/professionals/physician_gls/default.aspx#supportive.
Boyd C, Crawford C, Paat CF, et al: The impact of massage therapy on function in pain populations: A systematic review and meta-analysis of randomized controlled trials: Part II, cancer pain populations. Pain Med 17:1553-1568, 2016.
He Y, Guo X, May BH, Zhang AL, Liu Y, Lu C, Mao JJ, Xue CC, Zhang H. Clinical Evidence for Association of Acupuncture and Acupressure With Improved Cancer Pain: A Systematic Review and Meta-Analysis. JAMA Oncol. 2020 Feb 1;6(2):271-278. doi: 10.1001/jamaoncol.2019.5233.
Höxtermann MD, Haller H, Aboudamaah S, Bachemir A, Dobos G, Cramer H, Voiss P. Safety of acupuncture in oncology: A systematic review and meta-analysis of randomized controlled trials. Cancer. 2022 Jun 1;128(11):2159-2173. doi: 10.1002/cncr.34165.
Lin D, Ou Y, Li L, Wu K, Zhang Q, Yan J, Kuang K, Peng D. Acupuncture for postoperative gastrointestinal dysfunction in cancer: a systematic review and meta-analysis. Front Oncol. 2023 Jun 9;13:1184228. doi: 10.3389/fonc.2023.1184228.
Lv G, Zhao D, Li G, Qi M, Dong X, Li P. When experiencing a surgery: Gastrointestinal cancer patients" longitudinal trajectories in psychological stress and their association with quality of recovery. Asia Pac J Oncol Nurs. 2022 Apr 11;9(6):100064. doi: 10.1016/j.apjon.2022.04.003.
Coletta AM, Basen-Engquist KM, Schmitz KH. Exercise Across the Cancer Care Continuum: Why It Matters, How to Implement It, and Motivating Patients to Move. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-7. doi: 10.1200/EDBK_349635.
Takegawa N, Hirabayashi T, Tanaka S, et al. The impact of nutritional status in nivolumab-treated patients with advanced esophageal cancer. PLoS One. 2023 May 5;18(5):e0285365. doi: 10.1371/journal.pone.0285365.
Fabi A, Bhargava R, Fatigoni S, et al.; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment. Ann Oncol. 2020 Jun;31(6):713-723. doi: 10.1016/j.annonc.2020.02.016
Wang, Sa., Dai, Ws., Zhu, Jy. et al. Nasogastric tube feeding improves nutritional status and physical state in esophageal cancer patients during chemoradiotherapy: a retrospective study. Support Care Cancer 31, 341 (2023).
https://doi.org/10.1007/s00520-023-07780-w
Muscaritoli M, Arends J, Bachmann P, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr. 2021 May;40(5):2898-2913. doi: 10.1016/j.clnu.2021.02.005.
Boying Zhao, Yuan Luo and Renfu Lu. Evaluate the Effect of Home Enteral Nutrition Compared with Oral Diet after the Hospital Discharge of Subjects with Esophagectomy of Esophageal Cancer: A Systemic Review and Meta-analysis. Journal of Food and Nutrition Research. 2021; 9(11):571-578
Wilson, T.N., Nambiema, A., Porro, B. et al. Effectiveness of Physical Activity Interventions on Return to Work After a Cancer Diagnosis: A Systematic Review and Meta-analysis. J Occup Rehabil (2022).
https://doi.org/10.1007/s10926-022-10052-9
Andréa Karla Soares Montenegro, Donat Braz Júnior Diego de Sousa Dantas. Effects of physical exercise on the functional capacity and muscle strength of patients with gastric and esophageal cancer: a systematic review. Research, Society and Development, v. 11, n.11, e256111133596, 2022. DOI: http://dx.doi.org/10.33448/rsd-v11i11.33596
Liu, Y., Pettersson, E., Schandl, A. et al. Psychological distress after esophageal cancer surgery and the predictive effect of dispositional optimism: a nationwide population-based longitudinal study. Support Care Cancer 30, 1315–1322 (2022)
Приказ Минздрава России от 28.09.2020 N 1029н"Об утверждении перечней медицинских показаний и противопоказаний для санаторно-курортного лечения" (Зарегистрировано в Минюсте России 27.10.2020 N 60589
https://minjust.consultant.ru/documents/24249
Yuichiro Doki. Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma. N Engl J Med . 2022 Feb 3;386(5):449-462. doi: 10.1056/NEJMoa2111380
Jia Zhao. PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis. BMC Cancer volume 23, Article number: 1221 (2023)
Sun Young Rha, Lucjan Wyrwicz, Patricio Eduardo Yanez Weber, et zl. KEYNOTE-859 study of pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Outcomes in the protocol-specified PD-L1–selected populations. J Clin Oncol 41, 2023 (suppl 16; abstr 4014)
Y.Y. Janjigian, A. Kawazoe, Y. Bai, et al. Pembrolizumab plus trastuzumab and chemotherapy for HER2+ meta-static gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Survival results from the phase III, random-ized, double-blind, placebo-controlled KEYNOTE-811 study. Annals of Oncology (2023) 34 (suppl_2): S852-S886. 10.1016/S0923-7534(23)01930-0
L Assersohn, G Brown, D Cunningham, C Ward, J Oates, J S Waters, M E Hill, A R Norman. Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma. Ann Oncol 2004 Jan;15(1):64-9. doi: 10.1093/annonc/mdh007.
Alexandra Leary, L Assersohn, D Cunningham, A R Norman, G Chong, G Brown, P J Ross, C Costello, L Higgins, J Oates. A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy. Cancer Chemother Pharmacol. 2009;64(3):455-62.
Трякин А. А., Бесова Н. С., Волков Н. М., Гамаюнов С. В., Кононец П. В., Левченко Е. В. и соавт. Практические рекомендации по лекарственному лечению рака пищевода и пищеводножелудочного перехода. Практические рекомендации RUSSCO, часть 1. Злокачественные опухоли, 2024, DOI: 10.18027/2224-5057-2024-14-3s2-1.1-12 (электронная публикация, ttps://www.rosoncoweb.ru/standarts/RUSSCO/).
Navari R.M., Gray S.E., Kerr A.C. Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial. J Support Oncol 2011;9(5):188–95
Vanessa Piechotta, Anne Adams, Madhuri Haque, Benjamin Scheckel, Nina Kreuzberger, Ina Monsef, Karin Jordan, Kathrin Kuhr, Nicole Skoetz. Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis. Cochrane Database Syst Rev, 2021 Nov 16;11(11):CD012775
Владимирова Л.Ю., Гладков О.А., Королева И.А., Румянцев А.А., Семиглазова Т.Ю., Трякин А.А., Кутукова С.И., Овчинникова Е.Г., Новикова О.Ю., Корниецкая А.Л. Практические рекомендации по профилактике и лечению тошноты и рвоты у онкологических больных. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=nausea_vomiting
Chaoyang Chen, Ruoming Li, Ting Yang. Denosumab Versus Zoledronic Acid in the Prevention of Skeletal-related Events in Vulnerable Cancer Patients: A Meta-analysis of Randomized, Controlled Trials. Clinical Therapeutics 2020, 42(8): 1494–1507.e1.
Багрова С.Г., Басин Е.М., Борзов К.А., Бычкова Н.М., Деньгина Н. В., Копп М.В., Крылов В.В., Кочетова Т.Ю., Семиглазова Т.Ю. Профилактика и лечение патологии костной ткани при злокачественных новообразованиях. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=bone_pathology
Sonal Krishan, Nalinda Panditaratne, Rajeev Verma, Roderick Robertson. Incremental value of CT venography combined with pulmonary CT angiography for the detection of thromboembolic disease: systematic review and meta-analysis. AJR Am J Roentgenol 2011;196(5):1065–72.
Chinthaka B Samaranayake, James Anderson, Colm McCabe, Syeda Farah Zahir, John W Upham, Gregory Keir, Direct oral anticoagulants for cancer-associated venous thromboembolisms: a systematic review and network meta-analysis, Intern Med J,2022 Feb;52(2):272-281.
William Knoll, Nathan Fergusson, Victoria Ivankovic , Tzu-Fei Wang, Lucia Caiano, Rebecca Auer, Marc Carrier, Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature, Thromb Res, 2021 Aug:204:114-122.
Сомонова О.В., Антух Э.А., Варданян А.В., Громова Е.Г., Долгушин Б.И., Елизарова А.Л., Сакаева Д.Д., Сельчук В.Ю., Трякин А.А., Черкасов В.А. Практические рекомендации по профилактике и лечению тромбоэмболических осложнений у онкологических больных. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=thromboembolism
NCCN Guidelines. Prevention and Treatment of Cancer-Related Infections. v.1, 2021. https://www.nccn.org/professionals/physician_gls/pdf/infections.pdf.
Yoshimasa Kosaka, Yoshiaki Rai, Norikazu Masuda, et al. Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy. Support Care Cancer 2015 Apr;23(4):1137–43.
Mical Paul, Dafna Yahav, Abigail Fraser, Leonard Leibovici. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy, Volume 57, Issue 2, February 2006, Pages 176–189.
Сакаева Д.Д., Борисов К.Е., Булавина И.С., Когония Л.М., Курмуков И.А., Орлова Р.В., Шабаева М.М. Практические рекомендации по диагностике и лечению фебрильной нейтропении. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=febrile_neutropenia
B Vincenzi, A Russo, A Terenzio, et al. The use of SAMe in chemotherapy-induced liver injury. Crit Rev Oncol Hematol 2018 Oct;130:70–77.
Devika Remash, David S Prince, Catriona McKenzie, et al. Immune checkpoint inhibitor-related hepatotoxicity: A review. World J Gastroenterol 2021 Aug 28;27(32):5376–5391.
Ткаченко П.Е., Ивашкин В.Т., Маевская М.В. Практические рекомендации по коррекции гепатотоксичности, индуцированной противоопухолевой терапией. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=hepatotoxicity
Zhujun Mao, Keping Shen, Limin Zhu, et al. Comparisons of Cardiotoxicity and Efficacy of Anthracycline-Based Therapies in Breast Cancer: A Network Meta-Analysis of Randomized Clinical Trials. Oncol Res Treat 2019;42(7-8):405–413.
Albakri, Aref. Systolic heart failure: A review of clinical status and metaanalysis of diagnosis and clinical management methods. Trends in Res, 2018, 1(4), doi: 10.15761/TR.1000124.
Jasper Tromp, Wouter Ouwerkerk, Dirk J. van Veldhuisen, et al. A Systematic Review and Network-Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction. J Am Coll Cardiol HF. Dec 08, 2021.
Kashif Kalam, Thomas H.Marwick. Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis. Eur J Cancer 2013 Sep;49(13):2900–9.
Виценя М.В., Агеев Ф. Т., Орлова Р. В., Полтавская М.Г., Потиевская В.И. Практические рекомендации по коррекции кардиоваскулярной токсичности противоопухолевой лекарственной терапии. Практические рекомендации RUSSCO, часть 2 https://rosoncoweb.ru/standarts/?chapter=cardiovascular_toxicity
Jing Li, Hengxiu Yan. Skin toxicity with anti-EGFR monoclonal antibody in cancer patients: a meta-analysis of 65 randomized controlled trials. Cancer Chemother Pharmacol 2018 Oct;82(4):571–583.
Королева И.А., Болотина Л.В., Гладков О.А., Горбунова В.А., Когония Л.М., Круглова Л.С., Орлова Е.В., Орлова Р.В. Практические рекомендации по лекарственному лечению дерматологических реакций у пациентов, получающих противоопухолевую лекарственную терапию. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=dermatological_reactions
Emily J Martin, Andrew R Bruggeman, Vinit V Nalawade, et al. Palliative Radiotherapy Versus Esophageal Stent Placement in the Management of Patients With Metastatic Esophageal Cancer. J Natl Compr Canc Netw 2020 May;18(5):569–574.
M A E de van der Schueren, A Laviano, H Blanchard, et al. Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional and clinical outcomes during chemo(radio)therapy: current evidence and guidance for design of future trials. Ann Oncol. 2018 May; 29(5): 1141–1153.
Сытов А.В., Зузов С.А., Кукош М.Ю., Лейдерман И.Н., Обухова О.А., Потапов А.Л., Хотеев А.Ж. Практические рекомендации по нутритивной поддержке онкологических больных. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=nutritional_support
Perazella, Mark A. Onco-Nephrology. Renal Toxicities of Chemotherapeutic Agents Clinical Journal of the American Society of Nephrology, 2012 October, 7(10):p 1713-1721.
Han Li, Jinsheng Xu, Yaling Bai, Shenglei Zhang, Meijuan Cheng, Jingjing Jin. Nephrotoxicity in patients with solid tumors treated with anti-PD-1/PD-L1 monoclonal antibodies: a systematic review and meta-analysis. Investigational New Drugs, 2021, Volume 39, pages 860–870.
Songtao Li, Xiuyun He, Linjie Ruan, Ting Ye, Yulong Wen, Zhihua Song, Siying Hu, Yu Chen, Bo Peng, Shijie Li. Protective Effect of Mannitol on Cisplatin-Induced Nephrotoxicity: A Systematic Review and Meta-Analysis. Front Oncol. 2021; 11, Published online 2021 Dec 16.
Громова Е.Г., Бирюкова Л.С., Джумабаева Б.Т., Курмуков И.А. Практические рекомендации по коррекции нефротоксичности противоопухолевых препаратов. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=nephrotoxicity
NCCN guidelines. . Management of Immunotherapy-Related Toxicities. Version 4, 2021. https://www.nccn.org/professionals/physician_gls/pdf/immunotherapy.pdf.
Daniel H Johnson, Chrystia M Zobniw, Van A Trinh, et al. Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis. Journal for ImmunoTherapy of Cancer, 2018, article number: 103.
Guillermo De Velasco, Youjin Je, Dominick Bossé, Mark M. Awad, Patrick A. Ott, Raphael B. Moreira, Fabio Schutz, Joaquim Bellmunt, Guru P. Sonpavde, F. Stephen Hodi, Toni K. Choueiri. Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients. Cancer Immunol Res, 2017, 5 (4): 312–318
Hongchuan Zhang MD, Xuemei Li MD, Xingliang Huang MD, Junfeng Li MD, Hong Ma MD, Rui Zeng MD, Impact of corticosteroid use on outcomes of non–small-cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Journal of Clinical Pharmacy and Therapeutics, Volume 46, Issue4, August 2021, Pages 927-935
Проценко С.А., Баллюзек М.Ф., Васильев Д.А., Жукова Н.В., Новик А.В., Носов Д.А., Петенко Н.Н., Семенова А.И., Харкевич Г.Ю., Юдин Д.И. Практические рекомендации по управлению иммуноопосредованными нежелательными явлениями. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=immunerelated_adverse_events
P.Bossi, A.Antonuzzo, N.I.Cherny, et al. Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines. Annals of Oncology, 2018, 29(4): pages iv126-iv142.
D. E. Peterson, R.-J. Bensadoun, F. Roila. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Annals of Oncology 21 (Supplement 5): v261–v265, 2010.
Семиглазова Т.Ю., Беляк Н.П., Владимирова Л.Ю., Корниецкая А.Л., Королева И.А., Нечаева М.Н., Раджабова З.А., Телетаева Г.М., Ткаченко Е.В. Практические рекомендации по лечению и профилактике мукозитов. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=mucositis
Yasuo Ohashi, Yukari Uemura, Yasuhito Fujisaka, et al. Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials. Cancer Sci 2013 Apr;104(4):481–5.
Anat Gafter-Gvili 1, Benaya Rozen-Zvi, Liat Vidal, et al. Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia — systematic review and meta-analysis of randomised controlled trials. Acta Oncol 2013 Jan;52(1):18–29.
Орлова Р.В., Гладков О.А., Кутукова С.И., Копп М.В., Королева И.А., Ларионова В.Б., Моисеенко В.М., Поддубная И.В., Птушкин В.В. Практические рекомендации по лечению анемии при злокачественных новообразованиях. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=anemia
Fangyuan Zhang, Aomei Shen, Yinghui Jin, Wanmin Qiang. The management strategies of cancer-associated anorexia: a critical appraisal of systematic reviews. BMC Complement Altern Med. 2018; 18: 236.
Сытов А.В., Зузов С.А., Кукош М.Ю., Лейдерман И.Н., Потапов А.Л., Хотеев А.Ж. Практические рекомендации по лечению синдрома анорексии-кахексии у онкологических больных. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=anorexia-cachexia
Marcus Yeow, Shauna Soh, Ryan Yap, Serene Si Ning Goh, Charleen Shanwen Yeo, Zhiwen Joseph Lo. A systematic review and network meta-analysis of randomized controlled trials on choice of central venous access device for delivery of chemotherapy. Journal of Vascular Surgery_ Venous and limphatic disorders. V 10, issue 4, p 1184-1191
Исянгулова А.З., Шин А.Р., Петкау В.В. Центральный венозный доступ. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=central_venous_access
Firas Y Kreidieh, Hiba A Moukadem, and Nagi S El Saghir Overview, prevention and management of chemotherapy extravasation World J Clin Oncol. 2016 Feb 10; 7(1): 87–97.
Буйденок Ю.В., Обухова О.А. Рекомендации по профилактике и лечению последствий экстравазации противоопухолевых препаратов. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=extravasation_antitumor_drugs
Margaux Evenepoel, Vincent Haenen, Tom De Baerdemaecker, Mira Meeus, Nele Devoogdt, Lore Dams, Sophie Van Dijck, Elien Van der Gucht, An De Groef. Pain Prevalence During Cancer Treatment: A Systematic Review and Meta-Analysis. Pain Symptom Manage, 2022 Mar;63(3):e317-e335
Когония Л.М., Новиков Г.А., Орлова Р.В., Сидоров А.В., Королева И.А., Сакаева Д.Д. Практические рекомендации по лечению хронического болевого синдрома у взрослых онкологических больных. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=chronic_pain_syndrome
S. Rosello, I. Blasco, L. Garcıa Fabregat, A. Cervantes, K. Jordan. Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines. Annals of Oncology 28 (Supplement 4): iv100–iv118, 2017
Орлова Р.В., Жабина А.С., Иванова А.К., Наталенко К.Е., Телетаева Г.М. Практические рекомендации по лечению инфузионных реакций при проведении противоопухолевой лекарственной терапии. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=infusion_reactions
Khalis Mustafayev, Harrys Torres. Narrative review. Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies. Clinical Microbiology and Infection. Volume 28, Issue 10, October 2022, Pages 1321-1327
Феоктистова П.С., Винницкая Е.В., Нурмухаметова Е.А., Тихонов И.Н. Практические рекомендации по профилактике и лечению реактивации/обострения хронических вирусных гепатитов у пациентов, получающих противоопухолевую терапию. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=chronic_viral_hepatitis
Paola Alberti, Alessandro Salvalaggio, Andreas A. Argyriou, Jordi Bruna, Andrea Visentin, Guido Cavaletti, and Chiara Briani. Neurological Complications of Conventional and Novel Anticancer Treatments. Cancers (Basel). 2022 Dec; 14(24): 6088.
Латипова Д.Х., Андреев В.В., Маслова Д.А., Новик А.В., Проценко С.А. Неврологические осложнения противоопухолевой лекарственной терапии. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=neurological_complication
Для продолжения работы требуется
Registration
Предыдущая страница
Следующая страница
Table of contents
Список сокращений
Термины и определения
Рак пищевода и кардии
+
Список литературы
Приложение А1. Состав рабочей группы по разработке и пересмотру клинических рекомендаций
Приложение А2. Методология разработки клинических рекомендаций
Приложение А3. Справочные материалы, включая соответствие показаний к применению и противопоказаний, способов применения и доз лекарственных препаратов, инструкции по применению лекарственного препарата
Приложение Б. Алгоритмы действий врача
Приложение В. Информация для пациента
Приложение Г1-ГN. Шкалы оценки, вопросники и другие оценочные инструменты состояния пациента, приведенные в клинических рекомендациях
+
Данный блок поддерживает скрол*